Cipla gets USFDA nod for overactive bladder treating drug Industry-The Economic Times — September 2, 2016 comments off “We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA,” a company statement said here.
“We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA,” a company statement said here.